Literature DB >> 29891511

Primary lateral sclerosis-like picture in a patient with a remote history of anti-N-methyl-D- aspartate receptor (anti-NMDAR) antibody encephalitis.

Mubeen Janmohamed1, Wally Knezevic1, Merrilee Needham1, Sam Salman2,3.   

Abstract

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a well-recognised disorder, first fully characterised in 2007. The long-term sequelae reported thus far include relapses with typical, as well as partial aspects of the well-defined neuropsychiatric syndrome. Rarely, isolated atypical symptoms (diplopia, ataxia and tremor) have been reported as relapse phenomenon. We report a case of a patient with a remote history of likely anti-NMDAR encephalitis with the longest follow-up reported in the literature to date (22 years). The relapse presentation was of a purely upper motor neuron syndrome with a primary lateral sclerosis-like picture. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  immunology; motor neurone disease; neurology

Mesh:

Substances:

Year:  2018        PMID: 29891511      PMCID: PMC6011424          DOI: 10.1136/bcr-2017-224060

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.

Authors:  Ethan G Hughes; Xiaoyu Peng; Amy J Gleichman; Meizan Lai; Lei Zhou; Ryan Tsou; Thomas D Parsons; David R Lynch; Josep Dalmau; Rita J Balice-Gordon
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

2.  Analysis of relapses in anti-NMDAR encephalitis.

Authors:  I Gabilondo; A Saiz; L Galán; V González; R Jadraque; L Sabater; A Sans; A Sempere; A Vela; F Villalobos; M Viñals; P Villoslada; F Graus
Journal:  Neurology       Date:  2011-08-24       Impact factor: 9.910

3.  Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjögren syndrome.

Authors:  Giovanni Piccolo; Eleonora Tavazzi; Sven Jarius; Enrico Alfonsi; Lorenzo Cavagna; Laura Piccolo; Elisabetta Zardini; Raymond Voltz; Diego Franciotta
Journal:  Neurol Sci       Date:  2011-03-03       Impact factor: 3.307

4.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

5.  Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

Authors:  T Iizuka; F Sakai; T Ide; T Monzen; S Yoshii; M Iigaya; K Suzuki; D R Lynch; N Suzuki; T Hata; J Dalmau
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910

Review 6.  Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies.

Authors:  Francisco J Carvajal; Hayley A Mattison; Waldo Cerpa
Journal:  Neural Plast       Date:  2016-08-18       Impact factor: 3.599

Review 7.  Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations.

Authors:  Hilmar Bading
Journal:  J Exp Med       Date:  2017-02-16       Impact factor: 14.307

  7 in total
  1 in total

1.  International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis.

Authors:  Margherita Nosadini; Terrence Thomas; Michael Eyre; Banu Anlar; Thais Armangue; Susanne M Benseler; Tania Cellucci; Kumaran Deiva; William Gallentine; Grace Gombolay; Mark P Gorman; Yael Hacohen; Yuwu Jiang; Byung Chan Lim; Eyal Muscal; Alvin Ndondo; Rinze Neuteboom; Kevin Rostásy; Hiroshi Sakuma; Suvasini Sharma; Silvia Noemi Tenembaum; Heather Ann Van Mater; Elizabeth Wells; Ronny Wickstrom; Anusha K Yeshokumar; Sarosh R Irani; Josep Dalmau; Ming Lim; Russell C Dale
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.